Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL), sold 1,699 shares at $138.18 ($235K) on 2019-03-08, disclosed to the SEC on 2019-03-12.
Open-market sale of $235k CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.18 | 200 | $28K | 11.8% |
| 2 | $138.19 | 30 | $4K | 1.8% |
| 3 | $138.19 | 3 | $415 | 0.2% |
| 4 | $138.20 | 300 | $41K | 17.7% |
| 5 | $138.20 | 3 | $415 | 0.2% |
| 6 | $138.21 | 30 |
| $4K |
| 1.8% |
| 7 | $138.21 | 30 | $4K | 1.8% |
| 8 | $138.22 | 300 | $41K | 17.7% |
| 9 | $138.23 | 300 | $41K | 17.7% |
| 10 | $138.24 | 100 | $14K | 5.9% |
| 11 | $138.26 | 100 | $14K | 5.9% |
| 12 | $138.28 | 200 | $28K | 11.8% |
| 13 | $138.30 | 3 | $415 | 0.2% |
| 14 | $138.37 | 100 | $14K | 5.9% |
| Total | $138.23 avg | 1,699 | $235K | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |